首页> 外国专利> A:T TO T:A BASE EDITING THROUGH ADENINE DEAMINATION AND OXIDATION

A:T TO T:A BASE EDITING THROUGH ADENINE DEAMINATION AND OXIDATION

机译:A:T到T:通过腺嘌呤脱氨和氧化进行编辑的基础

摘要

The present disclosure provides for base editors which satisfy a need in the art for installation of targeted transversions of thymine (T) to adenine (A), or correspondingly, transversions of adenine (A) to thymine (T). The base editor domains include a nucleic acid programmable DNA binding protein and one or more of an adenosine deaminase or an oxidase domain. The base editors may be engineered through the use of continuous or non-continuous evolution systems, such as phage-assisted continuous evolution (PACE). In particular, the present disclosure provides for adenine-to-thymine (or thymine-to-adenine) base editor variants which satisfy deficiencies of those in art for single-base A:T to T:A transversion mutations. In some embodiments, methods for targeted nucleic acid editing are provided. In some embodiments, pharmaceutical compositions comprising, and vectors and kits for the generation of, targeted base editors are provided. In some embodiments, cells containing such vectors are provided. In some embodiments, methods of treatment comprising administering the base editors are provided.
机译:本公开提供了满足本领域技术需要的基础编辑器,其安装了胸腺嘧啶(T)向腺嘌呤(A)的目标转化,或者相应地,腺嘌呤(A)向胸腺嘧啶(T)的转化。碱基编辑域包括核酸可编程DNA结合蛋白和腺苷脱氨酶或氧化酶域中的一个或多个。可以通过使用连续或非连续进化系统(例如噬菌体辅助的连续进化(PACE))来设计基础编辑器。特别地,本公开提供了腺嘌呤至胸腺嘧啶(或胸腺嘧啶至腺嘌呤)的碱基编辑变体,其满足本领域技术人员对于单碱基A:T至T:A转化突变的缺陷。在一些实施方案中,提供了用于靶向核酸编辑的方法。在一些实施方案中,提供了药物组合物,其包含靶向的碱基编辑器,以及用于产生靶向的碱基编辑器的载体和试剂盒。在一些实施方案中,提供了包含此类载体的细胞。在一些实施例中,提供了包括管理基础编辑器的治疗方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号